drugset / Trial / NCT00673478
Tiotropium and Salmeterol PK Study in COPD Patients
CrossoverTreatment
Summary
The primary objective of this study is to characterize the pharmacokinetics (i.e. systemic exposure to tiotropium and salmeterol) of tiotropium qd + salmeterol qd or bid versus tiotropium qd and salmeterol bid following 4-week treatment periods in patients with chronic obstructive pulmonary disease (COPD).
Timeline
- Start
- 2008-05
- Primary completion
- 2009-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Salmeterol | Other / unclassified | — | — |
| Subject | Tiotropium | Other / unclassified | — | — |